NC parents struggling to find ADHD medication as drug shortages reach record high in US
There are more active drug shortages in the United States than ever, according to data from the American Society of Health-System Pharmacists and the University of Utah Drug Information Service. Parents in North Carolina are feeling the strain of the shortage especially for ADHD medication
Posted — UpdatedYour browser doesn't support HTML5 video.
Kerry Caskey and her two teenage sons take medication for their ADHD and the shortage has affected all three of them.
“There are different shortages with different medications, and we take different medications,” she said. “We all have an issue with the medicines that we take.”
Most insurance companies only cover the generic versions of Vyvanse and Focalin but do not cover the name-brand versions.
“It’s gotten better for some of the drugs,” Melissa Illig of White Oak Pharmacy said. “As far as Vyvanse, that has been a huge problem, especially since most of the insurance companies want to cover the generic, but we can’t get the generic.”
Caskey said not only is it getting harder to find the medication, but it’s becoming more expensive to do so.
“We pay $371 for a 30-day supply, so multiply that by three, and that’s what I’m paying every month for our medication,” she said.
Illig said continuing to pay out of pocket is not a sustainable strategy until the generic brands come back in stock. But parents like Caskey said they have to pay that bill if they or their children need the medication to function and feel like they are “at the mercy” of insurance companies.
“When I don’t have [my oldest son’s] medication, I get very worried. He can’t drive, he can’t work [and] he can’t go to school if he doesn’t have that,” she said. “It’s not just a school-day medication. It’s these kids' lives, and they depend on this to help them function.”
Largest drug shortage in a decade
The American Society of Health-System Pharmacists and the University of Utah Drug Information Service first started tracking drug shortages in 2001. Active shortages previously peaked in 2014, with 320 drugs in active shortage. Shortage levels have fluctuated in the decade, but have been steadily trending up since 2021 — reaching a record-high of 323 drugs in the first three months of 2024.
“All drug classes are vulnerable to shortages,” he wrote. “Some of the most worrying shortages involve generic sterile injectable medications, including cancer chemotherapy drugs and emergency medications stored in hospital crash carts and procedural areas. Ongoing national shortages of therapies for attention-deficit/hyperactivity disorder also remain a serious challenge for clinicians and patients.”
The drug shortage database maintained by the American Society of Health-System Pharmacists and the University of Utah is based on voluntary reports from practitioners, patients and others that are confirmed with manufacturers. This list often includes more drugs than the number considered to be in shortage by the US Food and Drug Administration because it captures broader impacts on providers and patients.
Increased demand can play a role in drug shortages, as with recent shortages of weight loss drugs. But more often, manufacturing and quality problems, such as supply chain gaps and discontinuations, are at the root.
Illig said she is hopeful a generic version of the ADHD medications will become more available, which will help other families afford the medication and make shortages less frequent.
“It’s a cheaper alternative and once the generic is released, it should be provided to the patient because it’s equivalent, but it’s not available, so that’s a problem,” she said.
Caskey, however, said that generic medications are not a one-size-fits-all solution for everyone.
“The generics are not one-to-one for the brand,” she said. “I have had people in my group who have said generic vyvanse doesn’t work for them, even if they can find it.”
The American Society of Health-System Pharmacists also has “serious concerns” about parts of the HHS’ proposal, notably the financial penalties for hospitals that lack resources to comply with the recommendations.
“We all know that managing shortages isn’t enough and is not a sustainable solution to the worsening crisis,” Abramowitz wrote. “Much work remains to be done at the federal level to fix the root causes of drug shortages.”
Related Topics
• Credits
Copyright 2024 by WRAL.com and CNN. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.